InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Albanna Rowena, Chief Executive Officer. Officer active across 1 company, notably Aditx Therapeutics, Inc.. In total, 4 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €2k. History available since 1 June 2021. The latest transaction was disclosed on 4 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Rowena Albanna is the Chief Operating Officer at Aditx Therapeutics, Inc. She is responsible for the daily operations of the company and the implementation of operational strategies. Her experience in the biopharmaceutical sector enables her to effectively lead growth initiatives.